| CASMASCI | progen | BOC | 進口現(xiàn)貨產(chǎn)品 | 胎牛血清 | 細胞培養(yǎng) | 提取試劑 | 轉(zhuǎn)染試劑 | 常規(guī)生化試劑 | ELISA試劑盒 | 抗體 | 細胞因子 | sigma aldrich(西格瑪) | Invitrogen(英駿) | Millipore | Abcam | CST | Roche | peprotech | prospec | pierce | BD Pharmingen | BD Biocoat | R&D | BioVision | Vector | Enzo life | eBioscience | ABR | Amresco | Cayman Chemical | 脂蛋白 | Merck | Qiagen(凱杰) | Santa cruz(三塔抗體) |
產(chǎn)品名稱:Tirapazamine
產(chǎn)品貨號:LKT T3468
產(chǎn)品規(guī)格:10 MG
Description
Is an experimental anticancer drug that is activated to a toxic radical only at very low levels of oxygen (hypoxia). Such levels are common in human solid tumors, a phenomenon known as tumor hypoxia.
Specifications
Cas No. 27314-97-2
Product ID T3468
Product Name Tirapazamine
Formula Wt. 178.15
Store Temp +4oC
References Denny WA (2004). "Prospects for hypoxia-activated anticancer drugs". Curr Med Chem Anti-Canc Agents 4 (5): 395